跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HAPI-C + Z - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
HAPI-C + Z
Approved
STANDARD
HAPI-C + Z
Lloyd Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
39e3c60461964d4d
Company
Lloyd Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
39e3c60461964d4d
Drug Approval Philippines Name
HAPI-C + Z
Product Name
HAPI-C + Z
Registration Number
DRP-9085
Brand Name
HAPI-C + Z
Generic Name
Ascorbic Acid + Zinc
Dosage Form
Capsule
Dosage Strength
500 mg (Equivalent to Sodium Ascobate 562.43mg)/10mg (Equivalent to Zinc Gluconate 70mg)
Manufacturer
Lloyd Laboratories, Inc.
Trader
Eadriex Pharmaceuticals Phils., Inc.
Issuance Date
25 May 2025
Expiry Date
17 August 2031
Pharmacologic Category
Vitamin and Mineral
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
39e3c60461964d4d
Type
Standard
Back to Philippines FDA Approvals